CellaVision AB (publ) (CLVSF)
| Previous close | 23.33 |
| Open | 20.24 |
| Bid | 22.73 x 29200 |
| Ask | 23.89 x 0 |
| Day's range | 20.24 - 20.24 |
| 52-week range | 16.72 - 24.21 |
| Volume | |
| Avg. volume | 3 |
| Market cap | 562.986M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 41.66 |
| EPS (TTM) | 0.56 |
| Earnings date | 24 Oct 2024 |
| Forward dividend & yield | 0.21 (0.89%) |
| Ex-dividend date | 06 May 2024 |
| 1y target est | N/A |
Simply Wall St.Exploring Value Opportunities on the Swedish Exchange in July 2024
As global markets navigate through a period marked by rising trade tensions and shifting investment trends towards value and small-cap shares, the Swedish stock market presents unique opportunities for those seeking undervalued assets. Amidst these conditions, identifying stocks that demonstrate strong fundamentals yet are trading below their intrinsic values could offer potential for significant returns.
Simply Wall St.Swedish Exchange Stocks Estimated Below Intrinsic Values in July 2024
As of July 2024, the Swedish stock market is showing signs of resilience amidst a complex global economic landscape marked by heightened political uncertainties in Europe and fluctuating bond yields. Investors seeking value might find opportunities in stocks that are currently estimated to be trading below their intrinsic values, particularly in an environment where cautious investment strategies could prevail due to the broader market conditions.
- Simply Wall St.
June 2024 Insights Into Three Swedish Stocks Estimated Below Value
Amidst a backdrop of political uncertainty and fluctuating markets across Europe, Sweden's equities market presents a unique landscape for investors seeking value. This article explores three Swedish stocks that appear undervalued in the current economic climate, offering potential opportunities for those looking to diversify their portfolios with international assets.
